As tobacco-free nicotine pouches become more widely available, understanding their effects on oral health has become an important area of scientific research. Every new study contributes to a growing evidence base that should inform clinicians, regulators, and policymakers. A recently published study in Oral Diseases examined oral lesions and dental status among users of tobacco-free…
Recent commentary from researchers at Stanford University has reignited debate over nicotine pouches, describing them as the latest strategy by the tobacco industry to sustain nicotine addiction while raising concerns about youth appeal, flavours, marketing, and the absence of long-term health data. These concerns reflect genuine public health priorities and deserve careful consideration. However, the…
As governments around the world grapple with the rapid emergence of modern nicotine products, a common regulatory challenge is becoming increasingly apparent. How can policymakers protect public health while ensuring that regulation remains proportionate to the risks different products actually present? Brazil has become one of the latest countries to confront this question. The National…
Public health discussions surrounding problematic drug use often focus on overdose prevention, infectious diseases, mental health, and access to treatment services. Yet one of the most significant contributors to illness and premature mortality among people who use drugs frequently receives far less attention: smoking. A recent briefing paper from the Global State of Tobacco Harm…
As nicotine pouches continue to expand across global markets, policymakers and public health stakeholders are increasingly asking important questions about their safety profile, long-term health implications, and appropriate regulation. A recent review published in Tobacco Induced Diseases, “Research on the Safety Risk of Oral Nicotine Products and Its Prospects,” contributes to this growing evidence base…
Nicotine should be regulated proportionately to its risks and in a manner that accelerates the decline of combustible smoking. It should not be governed through sweeping “endgame” narratives that treat all nicotine products as though they occupy the same place on the risk spectrum. Recent interventions from both The Guardian and the Government of Palau…
A Growing Divide in European Nicotine Policy The European Union is approaching a critical moment in nicotine regulation. As policymakers prepare for major revisions to the Tobacco Excise Directive (TED), the Tobacco Products Directive (TPD), and wider tobacco control legislation, a fundamental disagreement has emerged within European institutions. At the heart of the debate is…
Understanding the Findings and Their Policy Implications As nicotine pouches continue to emerge in markets around the world, regulators face a familiar challenge: how should policymakers respond when new products enter the market before dedicated regulatory frameworks are fully established? A recent study examining nicotine pouches sold in Karachi has contributed new data to this…
Why Emerging Nicotine Products Are Creating New Questions for Insurers The nicotine marketplace has changed dramatically over the past decade. Traditionally, insurance underwriting relied on a relatively simple distinction: applicants were generally classified as either smokers or non-smokers. This approach reflected decades of evidence demonstrating the substantial health risks associated with combustible tobacco use and…
A New Direction in European Nicotine Policy Over the past decade, Europe has been at the centre of some of the world’s most significant debates on tobacco harm reduction. Products such as nicotine pouches, vaping products, and heated tobacco products emerged as alternatives to combustible cigarettes and were often discussed through the lens of risk…